@article{ce9c9a39ba6246368fe9f6dde809ed71,
title = "Intramedullary sj{\"o}gren syndrome",
author = "S. Chahin and Garwood, {M. D.} and {St. Louis}, {E. K.} and Shivapour, {E. Torage} and Kelkar, {P. M.} and Granner, {M. A.}",
note = "Funding Information: Disclosure: Dr. Chahin and Dr. Garwood report no disclosures. Dr. St. Louis served on a scientific advisory board for Lundbeck Inc./Ovation Pharmaceuticals, Inc.; has served as a consultant for and received speaker honoraria from GlaxoSmithKline, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Shire plc, Impax Laboratories, Inc., and UCB; and has received research support from SCHWARZ PHARMA AG, Marinus Pharmaceuticals, Inc., NeuroVista Corporation, the CDC [Award 5 R49 CE721682-05 (PI)], the NIH [K12 510 17 3220 04000 11812015 (PI)], and the University of Iowa. Dr. Shivapour has served as a consultant for and received speaker honoraria from Teva Pharmaceutical Industries Ltd., Biogen Idec, Bayer Schering Pharma, and Merck Serono. Dr. Kelkar has received speaker honorarium from Biogen Idec. Dr. Granner served as a consultant for Lundbeck Inc./Ovation Pharmaceuticals, Inc.; served on speakers{\textquoteright} bureaus for UCB and GlaxoSmithKline; and received research support from Marinus Pharmaceuticals, Inc. and NeuroVista Corporation. ",
year = "2009",
month = dec,
doi = "10.1212/WNL.0b013e3181c55ced",
language = "English",
volume = "73",
pages = "2041--2042",
journal = "Neurology",
issn = "0028-3878",
number = "23",
}